Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinoma. - Agnese DM; Abdessalam SF; Burak WE Jr; Arnold MW; Soble D; Hinkle GH; Young D; Khazaeli MB; Martin EW Jr (Annals of surgical oncology, 2004)